TickerFacts.

Utah Medical Products Inc (UTMD): R&D Expense

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2011-12-31, 2012-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$668.0K
Year ended 2025-12-31
$687.0K
Trailing 12 months to 2026-06-30
+10.7%
3-year compound annual growth
+6.6%
5-year compound annual growth
+2.5%
10-year compound annual growth
$813.0K2009-12-31: $361.0K2010-12-31: $397.0K2011-12-31: -$518.0K2012-12-31: $563.0K2013-12-31: $491.0K2014-12-31: $460.0K2015-12-31: $522.0K2016-12-31: $475.0K2017-12-31: $447.0K2018-12-31: $454.0K2019-12-31: $483.0K2020-12-31: $486.0K2021-12-31: $526.0K2022-12-31: $493.0K2023-12-31: $560.0K2024-12-31: $813.0K2025-12-31: $668.0K$668.0K
2009-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$668.0K-17.8%2026-03-27, From 2025-01-01
2024-12-31$813.0K+45.2%2026-03-27, From 2024-01-01
2023-12-31$560.0K+13.6%2026-03-27, From 2023-01-01
2022-12-31$493.0K-6.3%2025-03-26, From 2022-01-01
2021-12-31$526.0K+8.2%2024-03-26, From 2021-01-01
2020-12-31$486.0K+0.6%2023-03-28, From 2020-01-01
2019-12-31$483.0K+6.4%2022-03-25, From 2019-01-01
2018-12-31$454.0K+1.6%2021-03-26, From 2018-01-01
2017-12-31$447.0K-5.9%2020-03-16, From 2017-01-01
2016-12-31$475.0K-9.0%2019-03-14, From 2016-01-01
2015-12-31$522.0K+13.5%2018-03-06, From 2015-01-01
2014-12-31$460.0K-6.3%2017-03-08, From 2014-01-01
2013-12-31$491.0K-12.8%2016-03-10, From 2013-01-01
2012-12-31$563.0Kn/c2015-03-12, From 2012-01-01
2011-12-31-$518.0Kn/c2014-03-12, From 2011-01-01
2010-12-31$397.0K+10.0%2013-03-07, From 2010-01-01
2009-12-31$361.0Kn/a2012-10-25, From 2009-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Utah Medical Products Inc (UTMD)2025-12-31$668.0K-17.8%
Interpace Biosciences, Inc. (IDXG)2025-12-31$642.0K-5.0%
Retractable Technologies Inc (RVP)2025-12-31$675.6K+0.2%
ClearPoint Neuro, Inc. (CLPT)2025-12-31$13.90M+12.1%
KORU Medical Systems, Inc. (KRMD)2025-12-31$4.39M-16.6%
SS Innovations International, Inc. (SSII)2025-12-31$3.69M+47.9%
SANUWAVE Health, Inc. (SNWV)2025-12-31$1.35M+101.0%
Orchestra BioMed Holdings, Inc. (OBIO)2025-12-31$58.19M+35.9%
TriSalus Life Sciences, Inc. (TLSI)2025-12-31$14.96M-15.4%

Compare UTMD, IDXG, RVP, CLPT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗